XML 41 R26.htm IDEA: XBRL DOCUMENT v3.20.4
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2020
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of customer concentration

Years Ended December 31, 

    

2020

    

2019

    

2018

 

Customer 1

31

%

32

%

33

%

Customer 2

24

%

25

%

23

%

Customer 3

19

%

23

%

21

%

Schedule of disaggregation of revenue and revenue recognized

Products and Services

Years Ended December 31, 

(in thousands)

    

2020

    

2019

    

2018

Sales of generic pharmaceutical products

$

147,257

$

128,729

$

117,451

Sales of branded pharmaceutical products

 

47,960

 

63,767

 

60,554

Sales of contract manufactured products

 

9,221

 

11,139

 

9,119

Royalties from licensing agreements

 

1,396

 

807

 

12,504

Product development services

 

1,858

 

1,125

 

1,019

Other(1)

 

783

 

980

 

929

Total net revenues

$

208,475

$

206,547

$

201,576

(1)Primarily includes laboratory services and royalties on sales of contract manufactured products

Timing of Revenue Recognition

Years Ended December 31, 

(in thousands)

    

2020

    

2019

    

2018

Performance obligations transferred at a point in time

$

206,617

$

205,422

$

200,557

Performance obligations transferred over time

 

1,858

 

1,125

 

1,019

Total

$

208,475

$

206,547

$

201,576

Schedule of accruals and allowances

The following table summarizes activity in the consolidated balance sheets for accruals and allowances for the years ended December 31, 2020, 2019, and 2018:

Accruals for Chargebacks, Returns, and Other Allowances

Administrative

Prompt

Government

Fees and Other

Payment

(in thousands)

    

Chargebacks

    

Rebates

    

Returns

    

Rebates

    

Discounts

Balance at December 31, 2018 (1)

$

39,007

$

8,974

$

12,552

$

7,353

$

2,009

Accruals/Adjustments

 

260,771

 

17,549

 

19,105

 

36,874

 

10,789

Credits Taken Against Reserve

 

(249,896)

(17,622)

 

(15,062)

 

(35,946)

 

(10,249)

Balance at December 31, 2019 (1)

$

49,882

$

8,901

$

16,595

$

8,281

$

2,549

Accruals/Adjustments

 

408,265

 

14,240

 

30,333

 

37,588

 

14,347

Credits Taken Against Reserve

 

(369,401)

(15,315)

 

(19,773)

 

(36,963)

 

(13,057)

Balance at December 31, 2020 (1)

$

88,746

$

7,826

$

27,155

$

8,906

$

3,839

(1)Chargebacks are included as a reduction to accounts receivable, net of chargebacks and other allowances in the consolidated balance sheets. Administrative Fees and Other Rebates and Prompt Payment Discounts are included as a reduction to accounts receivable, net of chargebacks and other allowances or accrued expenses and other in the consolidated balance sheets. Returns are included in returned goods reserve in the consolidated balance sheets. Government Rebates are included in accrued government rebates in the consolidated balance sheets.
Schedule of property, plant and equipment, useful life

Buildings and improvements

  

20

-

40

 

years

Machinery, furniture, and equipment

1

10

years

Schedule of Earnings per share, basic and diluted

Earnings per share for the years ended December 31, 2020, 2019, and 2018 are calculated for basic and diluted earnings (loss) per share as follows:

Basic

Diluted

(in thousands, except per share amounts)

Years Ended December 31, 

Years Ended December 31, 

  

2020

  

2019

  

2018

  

2020

  

2019

  

2018

Net (loss)/income

$

(22,548)

$

6,094

$

15,494

$

(22,548)

$

6,094

$

15,494

Net income allocated to restricted stock

 

 

(97)

 

(154)

 

 

(97)

 

(154)

Net (loss)/income allocated to common shares

$

(22,548)

$

5,997

$

15,340

$

(22,548)

$

5,997

$

15,340

Basic Weighted-Average Shares Outstanding

 

11,964

 

11,841

 

11,677

 

11,964

 

11,841

 

11,677

Dilutive effect of stock options and ESPP

 

 

103

 

95

Dilutive effect of Notes

96

Diluted Weighted-Average Shares Outstanding

 

11,964

 

12,040

 

11,772

(Loss)/Earnings per share

$

(1.88)

$

0.51

$

1.31

$

(1.88)

$

0.50

$

1.30

Schedule of revenue from company's revenue by geographic operations

The following table depicts the Company’s revenue by geographic operations during the following periods:

(in thousands)

Years Ended December 31, 

Location of Operations

    

    

2020

    

2019

    

2018

United States

$

202,881

$

199,663

$

196,886

Canada

 

5,594

 

6,884

 

4,690

Total Revenue

$

208,475

$

206,547

$

201,576

Schedule of company's property and equipment, net according to geographic location

The following table depicts the Company’s property and equipment, net according to geographic location as of:

(in thousands)

December 31, 2020

December 31, 2019

United States

$

26,960

$

26,708

Canada

 

14,309

 

13,843

Total property and equipment, net

$

41,269

$

40,551